Tag: Omicron

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Global Markets Pharma - 24.06.2022

Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

Omicron-specific vaccine candidates containing inactivated or “killed” coronaviruses approved for clinical trials

Global Markets Pharma - 18.04.2022

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for...

RedHill reports powerful inhibition of Omicron SARS-CoV-2 variant by the oral drug candidate

Drug Development Pharma - 14.04.2022

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for...

Roche offers molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants

Manufacturing Pharma - 18.03.2022

Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the...

WHO: COVID-19 vaccines in the context of the circulation of the Omicron

Global Markets Pharma - 09.03.2022

The World Health Organization, with the support of the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), continues to...

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

Regulatory Pharma - 25.01.2022

The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we...

Moderna aims to roll out a combined flu and COVID vaccine in 2023

Drug Development Pharma - 18.01.2022

The biotechnological company Moderna is working to create a single shot vaccine against both flu and coronavirus by autumn...

Gamaleya Center can develop COVID-19 vaccine based on several strains

Drug Development Pharma - 16.01.2022

Deputy director of the center Denis Logunov specified that a part of the vaccine based on the Wuhan or...

WHO Interim Statement on composition of current and future COVID-19 vaccines

Expert Opinion Pharma - 15.01.2022

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO...

Russia develops testing system capable of detecting Omicron coronavirus variant

Drug Development Pharma - 30.12.2021

A testing system capable of simultaneously detecting the coronavirus genome and deciding if it is the Omicron variant of...

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

Manufacturing Pharma - 27.12.2021

ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Tag: Omicron

Company

Headlines

Newsletter